AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
53.36
-1.68 (-3.05%)
At close: Jul 31, 2026, 4:00 PM EDT
54.00
+0.64 (1.20%)
After-hours: Jul 31, 2026, 7:34 PM EDT
AnaptysBio Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, AnaptysBio stock has a consensus rating of "Strong Buy" and an average price target of $87.09. The average 1-year stock price forecast is 63.21% higher than the current stock price, while the lowest is $70 (+31.18%) and the highest is $140 (+162.37%).
Price Target: $87.09 (+63.21%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for AnaptysBio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 7 | 8 | 8 | 8 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $75 | Buy | Maintains | $75 | +40.55% | Jul 31, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $95 | Buy | Reiterates | $95 | +78.04% | Jul 21, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $93 | Buy | Maintains | $93 | +74.29% | Jul 21, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $75 | Buy | Maintains | $75 | +40.55% | Jul 13, 2026 |
| UBS | UBS | Buy Maintains $76 | Buy | Maintains | $76 | +42.43% | Jul 1, 2026 |
Financial Forecast
Revenue This Year
94.28M
from 234.60M
Decreased by -59.81%
Revenue Next Year
153.19M
from 94.28M
Increased by 62.49%
EPS This Year
-0.23
from -0.46
EPS Next Year
5.24
from -0.23
EPS and Forward PE are based on non-GAAP adjusted numbers.